Empire Genomics

The companies will combine Empire's NGS services and FISH probe portfolio with Kromatid's Pinpoint probes and directional genomic hybridization technology.

Empire said it expects to generate $5 million or more in revenues from the Chinese market over the five-year term of the agreement with HemaTone.

The Buffalo, NY-based firm will use the proceeds to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products.

The permit will allow the company to offer DNA sequencing and molecular diagnostics for testing of cancer patients.

The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe.

The acquisition of the molecular diagnostic reagents firm is the first of several that Empire Genomics anticipates in order to accelerate the growth of its business.

NEW YORK (GenomeWeb) – Empire Genomics said today it has tapped Quadpharma to manufacture analyte-specific reagents using current good manufacturing principles for its clients in the research, clinical, and pharmaceutical industries.

NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

NEW YORK (GenomeWeb News) – Empire Genomics today said that its clinical laboratory facility has received CLIA certification and has been approved by the New York State Department of Health.

The University of Buffalo and its spin-off molecular diagnostics company, Empire Genomics, have announced a partnership with Life Technologies to develop and commercialize sequencing-based tests using the Ion Torrent Proton and PGM.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.